Share this
Apellis Pharmaceuticals – $402.5 Million Follow-On Offering
Ascendis Pharma – $575 Million Convertible Senior Notes Offering
argenx – $805 Million Follow-On Offering
CinCor Pharma – $212 Million IPO
Alvotech Agrees to Merge With SPAC Oaktree Acquisition Corp. II
Exscientia – $510.4 Million IPO
Ascendis Pharma – $460 Million Follow-On Offering
Adagio Therapeutics – $356 Million IPO
MaxCyte – $202 Million IPO
SOPHiA Genetics – $234 Million IPO
Elevation Oncology – $107 Million IPO
GH Research – $184 Million IPO
Verve Therapeutics – $307 Million IPO
Molecular Partners – $64 Million IPO
Centessa Pharmaceuticals – $380 Million IPO
Adagio Therapeutics Raises $336 Million Series C for COVID-19 Treatment and Prevention
Talaris Therapeutics – $150 Million IPO
Werewolf Therapeutics – $120 Million IPO
VectivBio – $147 Milion IPO
Finch Therapeutics – $128 Million IPO
Immunocore $312.1 Million Aggregate Financing
Edgewise Therapeutics – $202 Million IPO
LAVA Therapeutics – $107 Million IPO
Instil Bio – $368 Million IPO
NexImmune – $127 Million IPO
Immunocore – $297 Million IPO
Vor Biopharma – $203 Million IPO
Landos Biopharma – $100 Million IPO
Turnstone Biologics to Acquire Myst Therapeutics
Nanobiotix – $113 Million IPO
Ovid - $75 Million IPO
Opthea – $128 Million IPO
Prelude – $182 Million IPO
C4 Therapeutics – $210 Million IPO
Taysha Gene Therapies – $181 Million IPO
Orphazyme – $84 Million IPO
COMPASS Pathways – $147 Million IPO
Prelude Therapeutics – $182 Million IPO
Dyne Therapeutics – $268 Million IPO
Silence Therapeutics – Direct Listing
ADC Therapeutics – $233 Million IPO
iTeos Therapeutics – $201 Million IPO
Inventiva – $108 Million IPO
Akouos – $244 Million IPO
PolyPid – $69 Million IPO
Repare Therapeutics - $253 Million IPO
Avidity Biosciences - $289 Million IPO
Calliditas Therapeutics - $90 Million IPO
Legend Biotech - $487 Million IPO
Imara - $75 Million IPO
Bavarian Nordic - DKK$2.7 Billion Rights Issue
Shake Shack - $215 Million Combined Secondary Offerings
Zentalis Pharmaceuticals - $190 Million IPO
Passage Bio - $216 Million IPO
Schrodinger - $202 Million IPO
Reata Pharmaceuticals – $505 Million Follow-On Offering
argenx – $557 Million Follow-On Offering
Prevail Therapeutics Closes $50 Million Series B
Innate Pharma - $79 Million IPO
SpringWorks Therapeutics – $186 Million IPO
Bellus Health – $70 Million IPO
Karuna Therapeutics $103 million IPO
Morphic Therapeutics - $104 Million IPO
Akero Therapeutics - $106 Million IPO
Prevail Therapeutics $125 Million IPO
Bicycle Therapeutics - $61 Million IPO
Milestone Pharmaceuticals – $95 Million IPO
Applied Therapeutics $40 Million IPO
NextCure – $86 Million IPO
Precision BioSciences $145 Million IPO
Neuronetics – $108 Million IPO
Stealth BioTherapeutics $78 Million IPO
Gamida Cell – $50 Million IPO
LogicBio Therapeutics – $80.5 Million IPO
AGNC Closes $507.2 Million Mortgage REIT Equity Offering
Eidos Therapeutics – $122 Million IPO
MeiraGTx – $75 Million IPO
Verrica Pharmaceuticals – $86 Million IPO
ERYTECH – $144 Million IPO
Cooley Advises on Nightstar + NuCana IPOs
Zealand Pharma – $89 Million IPO
Neon Therapeutics – $100 Million IPO
UroGen – $66.9 Million IPO
Verona – $80 Million IPO
ERYTECH Closes €70.5 Million Private Placement to US + European Investors
Recro Pharma – $15 Million Follow-On
Advaxis – $30 Million Registered Direct Offering
Gemphire Therapeutics – $30 Million IPO
Syros – $58 Million IPO
Syros IPO – $58 Million
Selecta Biosciences – $74 Million IPO
Tricida – $256 Million IPO
Translate Bio – $122 Million IPO
Oncobiologics – $40 Million IPO and Private Placement
Inotek Pharmaceuticals – $50 Million Follow-On
Syndax – $58 Million IPO
AveXis – $95 Million IPO
Cooley Advises ERYTECH on €25.4 Million Private Placement
ERYTECH Private Placement
Strongbridge Biopharma IPO
Aclaris Therapeutics IPO
ProNAi Therapeutics - $158 Million IPO
Chiasma Completes $117 Million IPO
Celyad Completes IPO
Immunocore Limited Series A $320 Million Financing
Cooley Advises Immunocore on Largest European Private Life Sciences Financing on Record
Catabasis Completes $69 Million IPO
ProNAi – $158 Million IPO
DBV Technologies – $281.5 Million Follow-On Offering
Axovant Completes $362 Million IPO
Ascendis Pharma closes $124 million IPO
Bellicum Pharmaceuticals $160 million IPO
DBV Technologies Completes Concurrent Public Offerings
Cooley's Capital Markets Leadership Continues through 1H 2014
T2 Biosystems IPO
Vitae Pharmaceuticals Completes Initial Public Offering
Immune Design $63 Million Initial Public Offering
OnCore Biopharma Announces Merger Agreement with Tekmira Pharmaceuticals
Merus IPO – $61 Million
AbCellera Biologics - $556 million IPO